Johnson & Johnson Campaign tackles rising AF challenge The cardiac awareness raising campaign is being spearheaded by Arrythmia Alliance and Biosense Webster ‘Get Smart About AFIB’ is a new public health campaign developed to address the escalating epidemic of atrial fibrillation (AF), which has doubled in prevalence over the past decade and is predicted to rise by a further 70 per cent by 2030. The campaign aims to generate awareness, improve knowledge and encourage better detection of AF that affects more than 40,000 people in Ireland older than 50 years. The initiative is being spearheaded by Arrythmia Alliance and Biosense Webster, part of the Johnson & Johnson Family of Companies (J&J), to tackle the challenge of AF, now recognised as a major public health condition with high comorbidity, increased mortality and soaring healthcare costs. The campaign seeks to provide educational materials to doctors, both primary care providers and cardiologists, to support their work in detecting and diagnosing AF.